Asia stocks set to trade higher as hopes for a coronavirus vaccine rise
July 14, 2020 at 19:36 PM EDT
Biotech firm Moderna's potential vaccine to prevent Covid-19 produced a "robust" immune response, or neutralizing antibodies, in all 45 patients in its early stage human trial, according to newly released data published in the peer-reviewed New England Journal of Medicine.
